1-naphthylamine has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Quesada, R; Cañuelo, A; De Murcia, G; Martín-Oliva, D; Muñoz-Gámez, JA; Nuñez, MI; Oliver, FJ; Ruiz de Almodóvar, JM; Valenzuela, MT | 1 |
1 other study(ies) available for 1-naphthylamine and Breast Neoplasms
Article | Year |
---|---|
PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Topics: 1-Naphthylamine; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Caspases; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Naphthalimides; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Quinolones; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2005 |